International audience ; Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
International audience ; Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
International audience ; Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
International audience ; Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
International audience ; Background : In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy.Main body : As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care.Conclusion : In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
In: Bousquet , J J , Schünemann , H J , Togias , A , Erhola , M , Hellings , P W , Zuberbier , T , Agache , I , Ansotegui , I J , Anto , J M , Bachert , C , Becker , S , Bedolla-Barajas , M , Bewick , M , Bosnic-Anticevich , S , Bosse , I , Boulet , L P , Bourrez , J M , Brusselle , G , Chavannes , N , Costa , E , Cruz , A A , Czarlewski , W , Fokkens , W J , Fonseca , J A , Gaga , M , Haahtela , T , Illario , M , Klimek , L , Kuna , P , Kvedariene , V , Le , L T T , Larenas-Linnemann , D , Laune , D , Lourenço , O M , Menditto , E , Mullol , J , Okamoto , Y , Papadopoulos , N , Pham-Thi , N , Picard , R , Pinnock , H , Roche , N , Roller-Wirnsberger , R E , Rolland , C , Samolinski , B , Sheikh , A , Toppila-Salmi , S , Tsiligianni , I , Valiulis , A , Valovirta , E , Vasankari , T , Ventura , M T , Walker , S , Williams , S , Akdis , C A , Annesi-Maesano , I , Arnavielhe , S , Basagana , X , Bateman , E , Bedbrook , A , Bennoor , K S , Benveniste , S , Bergmann , K C , Bialek , S , Billo , N , Bindslev-Jensen , C , Bjermer , L , Blain , H , Bonini , M , Bonniaud , P , Bouchard , J , Briedis , V , Brightling , C E , Brozek , J , Buhl , R , Buonaiuto , R , Canonica , G W , Cardona , V , Carriazo , A M , Carr , W , Cartier , C , Casale , T , Cecchi , L , Cepeda Sarabia , A M , Chkhartishvili , E , Chu , D K , Cingi , C , Colgan , E , De Sousa , J C , Courbis , A L , Custovic , A , Cvetkosvki , B , Damato , G , Da Silva , J , Dantas , C , Dokic , D , Dauvilliers , Y , Dedeu , A , De Feo , G , Devillier , P , Di Capua , S , Dykewickz , M , Dubakiene , R , Ebisawa , M , El-Gamal , Y , Eller , E , Emuzyte , R , Farrell , J , Fink-Wagner , A , Fiocchi , A , Fontaine , J F , Gemicioǧlu , B , Schmid-Grendelmeir , P , Gamkrelidze , A , Garcia-Aymerich , J , Gomez , M , Diaz , S G , Gotua , M , Guldemond , N A , Guzmán , M A , Hajjam , J , O'Hourihane , J B , Humbert , M , Iaccarino , G , Ierodiakonou , D , Ivancevich , J C , Joos , G , Jung , K S , Jutel , M , Kaidashev , I , Kalayci , O , Kardas , P , Keil , T , Khaitov , M , Khaltaev , N , Kleine-Tebbe , J , Kowalski , M L , Kritikos , V , Kull , I , Leonardini , L , Lieberman , P , Lipworth , B , Lodrup Carlsen , K C , Loureiro , C C , Louis , R , Mair , A , Marien , G , Mahboub , B , Malva , J , Manning , P , De Manuel Keenoy , E , Marshall , G D , Masjedi , M R , Maspero , J F , Mathieu-Dupas , E , Matricardi , P M , Melén , E , Melo-Gomes , E , Meltzer , E O , Mercier , J , Miculinic , N , Mihaltan , F , Milenkovic , B , Moda , G , Mogica-Martinez , M D , Mohammad , Y , Montefort , S , Monti , R , Morais-Almeida , M , Mösges , R , Münter , L , Muraro , A , Murray , R , Naclerio , R , Napoli , L , Namazova-Baranova , L , Neffen , H , Nekam , K , Neou , A , Novellino , E , Nyembue , D , O'Hehir , R , Ohta , K , Okubo , K , Onorato , G , Ouedraogo , S , Pali-Schöll , I , Palkonen , S , Panzner , P , Park , H S , Pépin , J L , Pereira , A M , Pfaar , O , Paulino , E , Phillips , J , Plavec , D , Popov , T A , Portejoie , F , Price , D , Prokopakis , E P , Pugin , B , Raciborski , F , Rajabian-Söderlund , R , Reitsma , S , Rodo , X , Romano , A , Rosario , N , Rottem , M , Ryan , D , Salimäki , J , Sanchez-Borges , M M , Sisul , J C , Solé , D , Somekh , D , Sooronbaev , T , Sova , M , Spranger , O , Stellato , C , Stelmach , R , Ulrik , C S , Thibaudon , M , To , T , Todo-Bom , A , Tomazic , P V , Valero , A A , Valenta , R , Valentin-Rostan , M , Van Der Kleij , R , Vandenplas , O , Vezzani , G , Viart , F , Viegi , G , Wallace , D , Wagenmann , M , Wang , D Y , Waserman , S , Wickman , M , Williams , D M , Wong , G , Wroczynski , P , Yiallouros , P K , Yorgancioglu , A , Yusuf , O M , Zar , H J , Zeng , S , Zernotti , M , Zhang , L , Zhong , N S & Zidarn , M 2019 , ' Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases ' , Clinical and Translational Allergy , vol. 9 , 44 . https://doi.org/10.1186/s13601-019-0279-2
Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhi-nitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
BackgroundIn all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy.Main bodyAs an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care.ConclusionIn 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
In: Bousquet , J J , Schünemann , H J , Togias , A , Erhola , M , Hellings , P W , Zuberbier , T , Agache , I , Ansotegui , I J , Anto , J M , Bachert , C , Becker , S , Bedolla-Barajas , M , Bewick , M , Bosnic-Anticevich , S , Bosse , I , Boulet , L P , Bourrez , J M , Brusselle , G , Chavannes , N , Costa , E , Cruz , A A , Czarlewski , W , Fokkens , W J , Fonseca , J A , Gaga , M , Haahtela , T , Illario , M , Klimek , L , Kuna , P , Kvedariene , V , Le , L T T , Larenas-Linnemann , D , Laune , D , Lourenço , O M , Menditto , E , Mullol , J , Okamoto , Y , Papadopoulos , N , Pham-Thi , N , Picard , R , Pinnock , H , Roche , N , Roller-Wirnsberger , R E , Rolland , C , Samolinski , B , Sheikh , A , Toppila-Salmi , S , Tsiligianni , I , Valiulis , A , Valovirta , E , Vasankari , T , Ventura , M T , Walker , S , Williams , S , Akdis , C A , Annesi-Maesano , I , Arnavielhe , S , Basagana , X , Bateman , E , Bedbrook , A , Bennoor , K S , Benveniste , S , Bergmann , K C , Bialek , S , Billo , N , Bindslev-Jensen , C , Bjermer , L , Blain , H , Bonini , M , Bonniaud , P , Bouchard , J , Briedis , V , Brightling , C E , Brozek , J , Buhl , R , Buonaiuto , R , Canonica , G W , Cardona , V , Carriazo , A M , Carr , W , Cartier , C , Casale , T , Cecchi , L , Cepeda Sarabia , A M , Chkhartishvili , E , Chu , D K , Cingi , C , Colgan , E , De Sousa , J C , Courbis , A L , Custovic , A , Cvetkosvki , B , Damato , G , Da Silva , J , Dantas , C , Dokic , D , Dauvilliers , Y , Dedeu , A , De Feo , G , Devillier , P , Di Capua , S , Dykewickz , M , Dubakiene , R , Ebisawa , M , El-Gamal , Y , Eller , E , Emuzyte , R , Farrell , J , Fink-Wagner , A , Fiocchi , A , Fontaine , J F , Gemicioǧlu , B , Schmid-Grendelmeir , P , Gamkrelidze , A , Garcia-Aymerich , J , Gomez , M , Diaz , S G , Gotua , M , Guldemond , N A , Guzmán , M A , Hajjam , J , O'Hourihane , J B , Humbert , M , Iaccarino , G , Ierodiakonou , D , Ivancevich , J C , Joos , G , Jung , K S , Jutel , M , Kaidashev , I , Kalayci , O , Kardas , P , Keil , T , Khaitov , M , Khaltaev , N , Kleine-Tebbe , J , Kowalski , M L , Kritikos , V , Kull , I , Leonardini , L , Lieberman , P , Lipworth , B , Lodrup Carlsen , K C , Loureiro , C C , Louis , R , Mair , A , Marien , G , Mahboub , B , Malva , J , Manning , P , De Manuel Keenoy , E , Marshall , G D , Masjedi , M R , Maspero , J F , Mathieu-Dupas , E , Matricardi , P M , Melén , E , Melo-Gomes , E , Meltzer , E O , Mercier , J , Miculinic , N , Mihaltan , F , Milenkovic , B , Moda , G , Mogica-Martinez , M D , Mohammad , Y , Montefort , S , Monti , R , Morais-Almeida , M , Mösges , R , Münter , L , Muraro , A , Murray , R , Naclerio , R , Napoli , L , Namazova-Baranova , L , Neffen , H , Nekam , K , Neou , A , Novellino , E , Nyembue , D , O'Hehir , R , Ohta , K , Okubo , K , Onorato , G , Ouedraogo , S , Pali-Schöll , I , Palkonen , S , Panzner , P , Park , H S , Pépin , J L , Pereira , A M , Pfaar , O , Paulino , E , Phillips , J , Plavec , D , Popov , T A , Portejoie , F , Price , D , Prokopakis , E P , Pugin , B , Raciborski , F , Rajabian-Söderlund , R , Reitsma , S , Rodo , X , Romano , A , Rosario , N , Rottem , M , Ryan , D , Salimäki , J , Sanchez-Borges , M M , Sisul , J C , Solé , D , Somekh , D , Sooronbaev , T , Sova , M , Spranger , O , Stellato , C , Stelmach , R , Ulrik , C S , Thibaudon , M , To , T , Todo-Bom , A , Tomazic , P V , Valero , A A , Valenta , R , Valentin-Rostan , M , Van Der Kleij , R , Vandenplas , O , Vezzani , G , Viart , F , Viegi , G , Wallace , D , Wagenmann , M , Wang , D Y , Waserman , S , Wickman , M , Williams , D M , Wong , G , Wroczynski , P , Yiallouros , P K , Yorgancioglu , A , Yusuf , O M , Zar , H J , Zeng , S , Zernotti , M , Zhang , L , Zhong , N S , Zidarn , M , the ARIA Study Group & the MASK Study Group 2019 , ' Next-generation ARIA care pathways for rhinitis and asthma : A model for multimorbid chronic diseases ' , Clinical and Translational Allergy , vol. 9 , no. 1 , 44 . https://doi.org/10.1186/s13601-019-0279-2
Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhi-nitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
In: Bousquet , J J , Schünemann , H J , Togias , A , Erhola , M , Hellings , P W , Zuberbier , T , Agache , I , Ansotegui , I J , Anto , J M , Bachert , C , Becker , S , Bedolla-Barajas , M , Bewick , M , Bosnic-Anticevich , S , Bosse , I , Boulet , L P , Bourrez , J M , Brusselle , G , Chavannes , N , Costa , E , Cruz , A A , Czarlewski , W , Fokkens , W J , Fonseca , J A , Gaga , M , Haahtela , T , Illario , M , Klimek , L , Kuna , P , Kvedariene , V , Le , L T T , Larenas-Linnemann , D , Laune , D , Lourenço , O M , Menditto , E , Mullol , J , Okamoto , Y , Papadopoulos , N , Pham-Thi , N , Picard , R , Pinnock , H , Roche , N , Roller-Wirnsberger , R E , Rolland , C , Samolinski , B , Sheikh , A , Toppila-Salmi , S , Tsiligianni , I , Bindslev-Jensen , C , Eller , E , Ulrik , C S & ARIA Study Group 2019 , ' Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases ' , Clinical and Translational Allergy , vol. 9 , 44 . https://doi.org/10.1186/s13601-019-0279-2
Background: In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body: As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion: In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
International audience ; Background : In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy.Main body : As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted "patient activation", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Santé as a Good Practice in the field of digitally-enabled, integrated, person-centred care.Conclusion : In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
International audience ; Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
International audience ; Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
International audience ; Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system for integrated care with organizational health literacy. MASK (Mobile Airways Sentinel NetworK) (1), a new development of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) (2), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing reallife integrated care pathways (ICPs) (3)-centred around the patient with rhinitis and using mHealth monitoring of environmental exposure (4). An expert meeting took place at the Pasteur Institute in Paris, December 3, 2018. The aim was to discuss nextgeneration care pathways: (I) Patient participation, health literacy and self-care through technology-assisted "patient activation"; (II) Implementation of care pathways by pharmacists and (III) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) assessed by mobile technology. The EU (5) and global political agendas are of great importance in supporting health care transformation. MASK has been recognized by DG Santé as a Good Practice (6) in the field of digitally-enabled, integrated, person-centred care. The one-day meeting objectives were clear (Figure 1). The meeting was followed by a workshop. The present paper reports the background of the two-day meeting. [.] ; info:eu-repo/semantics/publishedVersion